Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.6424
-0.05-7.14%
At close: -
$0.6400
-0.00240-0.37%
After Hours: 7:50 PM EDT
Comments
Loading...
Tenaya Therapeutics Analyst Ratings and Price Targets | NASDAQ:TNYA | Benzinga
Tenaya Therapeutics Inc has a consensus price target of $8.33 based on the ratings of 7 analysts. The high is $18 issued by HC Wainwright & Co. on February 3, 2025. The low is $5 issued by Morgan Stanley on March 12, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Morgan Stanley, and Chardan Capital on March 13, 2025, March 12, 2025, and March 12, 2025, respectively. With an average price target of $6.67 between Canaccord Genuity, Morgan Stanley, and Chardan Capital, there's an implied 941.67% upside for Tenaya Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Morgan Stanley
Chardan Capital
HC Wainwright & Co.
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Tenaya Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 837.5% | Canaccord Genuity | Whitney Ijem46% | $18 → $6 | Maintains | Buy | Get Alert |
| 03/12/2025 | Buy Now | 681.25% | Morgan Stanley | Matthew Harrison61% | $15 → $5 | Maintains | Overweight | Get Alert |
| 03/12/2025 | Buy Now | 1306.25% | Chardan Capital | Geulah Livshits46% | $18 → $9 | Maintains | Buy | Get Alert |
| 03/11/2025 | Buy Now | 681.25% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $5 | Maintains | Buy | Get Alert |
| 02/03/2025 | Buy Now | 2712.5% | HC Wainwright & Co. | Emily Bodnar39% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 01/14/2025 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2024 | Buy Now | 2712.5% | Chardan Capital | Geulah Livshits46% | $18 → $18 | Maintains | Buy | Get Alert |
| 12/18/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/26/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | 2712.5% | Chardan Capital | Geulah Livshits46% | $20 → $18 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | 2400% | Canaccord Genuity | Whitney Ijem46% | $16 → $16 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 07/08/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 06/10/2024 | Buy Now | — | William Blair | Sami Corwin11% | — | Initiates | → Outperform | Get Alert |
| 05/16/2024 | Buy Now | 2400% | Canaccord Genuity | Whitney Ijem46% | $18 → $16 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | Buy Now | 3025% | Chardan Capital | Geulah Livshits46% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | Buy Now | 2712.5% | Canaccord Genuity | Whitney Ijem46% | $19 → $18 | Maintains | Buy | Get Alert |
| 03/19/2024 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/30/2023 | Buy Now | 993.75% | Leerink Partners | Mani Foroohar49% | → $7 | Initiates | → Outperform | Get Alert |
| 10/09/2023 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | 3493.75% | Chardan Capital | Geulah Livshits46% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 2556.25% | Canaccord Genuity | Whitney Ijem46% | $18 → $17 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 2087.5% | Morgan Stanley | Matthew Harrison61% | $13 → $14 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | Buy Now | 3493.75% | Chardan Capital | Geulah Livshits46% | $24 → $23 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | → $18 | Reiterates | Buy → Buy | Get Alert |
| 03/09/2023 | Buy Now | 3650% | Chardan Capital | Geulah Livshits46% | $28 → $24 | Maintains | Buy | Get Alert |
| 03/09/2023 | Buy Now | 2712.5% | HC Wainwright & Co. | Joseph Pantginis46% | $25 → $18 | Maintains | Buy | Get Alert |
| 01/24/2023 | Buy Now | 1931.25% | Morgan Stanley | Matthew Harrison61% | $15 → $13 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | 4275% | Chardan Capital | Geulah Livshits46% | $30 → $28 | Maintains | Buy | Get Alert |
| 11/08/2022 | Buy Now | 3181.25% | Canaccord Genuity | Whitney Ijem46% | → $21 | Initiates | → Buy | Get Alert |
| 08/11/2022 | Buy Now | 4587.5% | Chardan Capital | Geulah Livshits46% | $31 → $30 | Maintains | Buy | Get Alert |
| 06/15/2022 | Buy Now | 3806.25% | HC Wainwright & Co. | Joseph Pantginis46% | → $25 | Initiates | → Buy | Get Alert |
| 05/17/2022 | Buy Now | 2243.75% | Morgan Stanley | Matthew Harrison61% | $19 → $15 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Tenaya Therapeutics (TNYA) stock?
The latest price target for Tenaya Therapeutics (NASDAQ:TNYA) was reported by Canaccord Genuity on March 13, 2025. The analyst firm set a price target for $6.00 expecting TNYA to rise to within 12 months (a possible 837.50% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenaya Therapeutics (TNYA)?
The latest analyst rating for Tenaya Therapeutics (NASDAQ:TNYA) was provided by Canaccord Genuity, and Tenaya Therapeutics maintained their buy rating.
When was the last upgrade for Tenaya Therapeutics (TNYA)?
There is no last upgrade for Tenaya Therapeutics
When was the last downgrade for Tenaya Therapeutics (TNYA)?
There is no last downgrade for Tenaya Therapeutics.
When is the next analyst rating going to be posted or updated for Tenaya Therapeutics (TNYA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Tenaya Therapeutics (TNYA) correct?
While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a maintained with a price target of $18.00 to $6.00. The current price Tenaya Therapeutics (TNYA) is trading at is $0.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.